Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing–Remitting Multiple Sclerosis: A Real-World Study from Jordan

<i>Background and Objectives</i>: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system with rising prevalence in the Middle East. Real-world comparative data on disease-modifying therapies from this region remain limited. This retrospective study compared the clinica...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Arwa Al Anber, Ola Abu Al Karsaneh, Dua Abuquteish, Osama Abdallah, Mohammad A. Issa, Mohammad Sa’adeh, Dena Kilani
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2026-01-01
Serie:	Medicina
Soggetti:	multiple sclerosis relapsing–remitting MS fingolimod interferon beta-1a annualized relapse rate Jordan
Accesso online:	https://www.mdpi.com/1648-9144/62/1/203
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!